-
Univercells Introduces Vaccine Manufacturing Platform
americanpharmaceuticalreview
January 14, 2019
Univercells announced the commercial launch of its proprietary NevoLine bioproduction system for vaccines. The system was initially developed as part of a $12 million Grand Challenges grant awarded by .....
-
Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons
fiercepharma
January 09, 2019
It's no secret that Sanofi has had a rough time marketing its world-first dengue vaccine, and at the J.P. Morgan Healthcare Conference, vaccine head David Loew told FiercePharma the company gleaned some lessons from the troubled launch.
-
The Strictest Law for Vaccine: China to Separately Legislate for Vaccine Supervision
PharmaSources/Changlin
January 02, 2019
China to separately legislate for vaccine supervision: the law has been submitted to the NPC for deliberation for the first time on Dec. 23, which will be the strictest Law for the vaccine industry in the country.
-
FDA Approves VAXELIS
americanpharmaceuticalreview
December 29, 2018
The U.S. Food and Drug Administration (FDA) has approved VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed.....
-
Independent DMC Recommends Trial Discontinuation of Staphylococcus aureus Vaccine
americanpharmaceuticalreview
December 29, 2018
Pfizer announced the Phase 2b trial STRIVE (STaphylococcus aureus SuRgical Inpatient Vaccine Efficacy) evaluating the company’s investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (PF-06290510) is being discontinued due to futility....
-
Merck’s Ebola vaccine has 'major impact,' but U.S. should help as outbreak worsens: experts
fiercepharma
December 19, 2018
Merck & Co.’s experimental Ebola vaccine rVSV-ZEBOV has been deployed widely in the Democratic Republic of Congo.
-
Croda Acquires Vaccine Adjuvant Specialist Brenntag Biosector
americanpharmaceuticalreview
December 19, 2018
Croda has signed a definitive agreement with Brenntag Nordic A/S to acquire Brenntag Biosector, for a total consideration of €72 million in cash....
-
WHO worries Merck's Ebola vaccine will run short: report
fiercepharma
December 13, 2018
Nearly five months into an Ebola outbreak in the Democratic Republic of Congo, the disease is spreading closer to urban population centers, and that has health officials worried the vaccine stockpile won't meet demand, Stat reports.
-
Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever
b3cnewswire
December 13, 2018
Batavia Biosciences announces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine.
-
Sanofi may airlift flu shots into the U.K. in no-deal Brexit
fiercepharma
December 12, 2018
Several drugmakers are already stockpiling drugs in case of a no-deal Brexit.